Latest Articles
-
A Better Buy: CVS Health Or Cigna?
CVS Health (NYSE:CVS) has gained roughly 17% since the March 23 lows of this year, while Cigna (NYSE:CI) has fared much better and gained 39% over that same period. The health insurance companies have benefited in the current crisis due to lower ...
-
CVS Health Stock Appears Oversold At $65
After a 23% rise since the March 23 lows of this year, at the current price of around $65 per share we believe CVS Health’s stock (NYSE: CVS) looks attractive and it has significant room for growth. CVS stock has moved from $53 to $64 off t...
-
Is CVS Health Oversold At $63?
CVS Health’s stock (NYSE: CVS) has lost 15% of its value year-to-date, currently trading at levels of around $63. While the stock fell close to 30% to about $52 as the markets collapsed in March, it has risen by 21% from those lows. Why? While t...
-
Health Insurance Stocks Poised For Gains After COVID-19
Major health insurance companies have seen their stock prices decline by an average of over -4% year-to-date, due to the coronavirus pandemic. While CVS Health’s stock (NYSE:CVS) is down by about 15% year-to-date, UnitedHealth Group (NYSE:U...
-
At Current Levels of $60 Is CVS Health Cheaper Than UnitedHealth Group?
The health insurance companies have not seen any significant impact of the current coronavirus crisis, and they have fared much better than the broader markets. While UnitedHealth Group (NYSE:UNH) has seen 6.8% growth since early February, after ...
-
After An 8% Decline Is CVS Health A Better Buy Than Kroger?
The retail pharmacies have not been immune to the current coronavirus crisis, although they have fared somewhat better than the broader markets. While CVS Health (NYSE:CVS) has declined -8% since early February, after the WHO declared the corona...
-
Is CVS Health Stock Oversold At $60?
After almost a 20% decline in stock since the beginning of this year, we believe that CVS Health (NYSE: CVS) stock is likely oversold at the current price of $60 per share and it has a significant upside. The key is CVS Health’s stock is st...
-
Can CVS Health Be A Safe Bet In The Current Stock Market Correction?
CVS Health (NYSE: CVS) appears to be a safer bet in the current stock market correction, as it could see a pickup in sales of OTC products with the coronavirus outbreak. While the stock has declined due to the coronavirus/oil price war crisis, go...
-
What Are CVS Health’s Key Sources of Revenue?
CVS Health (NYSE:CVS) is the largest pharmacy services provider in the US comprising of the largest network of retail pharmacy stores nationwide along with pharmacy services and claims processing. The company’s pharmacy business, which mak...
-
How Large Is Cost of Goods Sold Expense For CVS Health?
CVS Health (NYSE:CVS) spent $146 billion in cost of goods sold (COGS) expenses in 2016, and the figure increased to $156 billion in 2018, driven by growth in revenues. As a percentage of revenue, COGS declined from 83% in 2016 to 80% in 2018. It...
-
Pharmacy Services Segment Leads CVS Health’s Revenue Growth In Q1 2019
CVS Health (NYSE:CVS) announced its Q1 2019 results recently, followed by a conference call with analysts. The company’s revenue beat consensus and was recorded at $61.6 billion, up by 34.7% y-o-y. The revenue increase was primarily drive...
-
Will Pharmacy Services Segment Push Growth For CVS In Q1 2019?
CVS Health (NYSE:CVS) is set to announce its Q1 2019 results on May 1, 2019, followed by a conference call with analysts. The market expects the company to report revenue close to $60.5 billion in Q1 2019, which would be an increase of 32.3% on ...
-
Is CVS Health Fairly Valued?
As per our Trefis Valuation methodology CVS Health (NYSE:CVS) stock is worth $62 which is about 15% higher than the current market price. Our Price Estimate is based on a P/E multiple of 10.84 and an earnings estimate of $5.80 for FY 2019. The ...
-
What Are CVS’s Key Sources Of Revenue?
CVS Health (NYSE:CVS) has continued with its growth momentum the past few years, primarily driven by higher prescription volumes within the retail pharmacy business. The top line got a major boost by a strong Pharmacy Services segment, benefitin...
-
CVS Delivers A Beat In Its Q4 Earnings
CVS Health (NYSE:CVS), the second largest drugstore chain in the U.S., has posted stronger than expected results in its fourth quarter 2018 . The company posted a 12.5% increase in sales to $54.4 billion with adjusted earnings reported at $2.14...
